<DOC>
	<DOC>NCT00161798</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and immunogenicity of three different concentrations of a TBE vaccine will be investigated in healthy children aged 6 to 16 years.</brief_summary>
	<brief_title>Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Tick-Borne</mesh_term>
	<criteria>Male and female children will be eligible for participation in this study if: they are 6 years (from the 6th birthday) to 16 years old (to the last day before the 16th birthday); they are clinically healthy; their legal representative and if older than 8 years the volunteer understands the nature of the study, agrees to its provisions and gives written informed consent; their legal representative agrees to keep a Volunteer Diary. For safety reasons female volunteers capable of bearing children have to fulfill the following inclusion criteria at study start: negative pregnancy test at study start; they agree to employ adequate birth control measures for the duration of the study. Children will be excluded from participation in this study if they: have a history of any previous TBE vaccination; have a history of TBE infection or show evidence of a latent TBE infection (as demonstrated by screening ELISA &gt; 126 VIEU/ml and / or neutralization test &gt; 1:10); have a history of allergic reactions, in particular to one of the components of the vaccine; have received antipyretics within 4 hours prior to the first TBE vaccination; suffer from a disease that cannot be effectively treated or stabilized; suffer from a disease (e.g. autoimmune disease) or are undergoing a form of treatment that can be expected to influence immunological functions; suffer from chronic, degenerative and / or inflammatory disease of the central nervous system; are known to be HIV positive (a special HIV test is not required for the purpose of the study); suffer from a febrile illness at study entry; have a history of vaccination against yellow fever and / or Japanese Bencephalitis; are participating simultaneously in another clinical trial. if female, are pregnant or breast feeding Volunteers who meet the inclusion / exclusion criteria, but have a febrile illness (body temperature &gt;= 38Â° C, measured orally) at the scheduled time of vaccination, will not be vaccinated before their body temperature returns to normal.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>